利用有效结核疫苗方案识别小鼠模型中的保护性免疫应答
本研究在小鼠中评估了BCG初免后经鼻给予ChAdOx1.85A和MVA85A(B-C-M)方案诱导的效应与记忆免疫应答,以识别保护相关免疫标志。该方案诱导了系统和肺部CD4+、CD8+ T细胞中强的Ag85A特异性细胞因子应答。肺实质CXCR3+KLRG1-Ag85A特异性记忆CD4+ T细胞在B-C-M组显著增加,且该细胞群与方案保护效力相关。
要点
- B-C-M方案在小鼠中诱导系统和肺部的Ag85A特异性CD4+和CD8+ T细胞细胞因子应答。
- 肺实质CXCR3+KLRG1-Ag85A特异性记忆CD4+ T细胞在B-C-M组显著增加。
- 该记忆CD4+ T细胞群与B-C-M方案的保护效力相关,可能对结核分枝杆菌感染有保护作用。
核心结论
- B-C-M结核疫苗方案在小鼠中诱导的肺实质CXCR3+KLRG1-Ag85A特异性记忆CD4+ T细胞与保护效力相关,可能具有重要保护作用。
研究设计与样本
- 在小鼠模型中评估BCG初免后经鼻给予ChAdOx1.85A和经鼻或皮内给予MVA85A(B-C-M)方案诱导的效应与记忆免疫应答。
主要发现
- B-C-M方案诱导了系统和肺部CD4+与CD8+ T细胞中强的Ag85A特异性细胞因子应答。
- 肺实质CXCR3+KLRG1-Ag85A特异性记忆CD4+ T细胞在B-C-M组较BCG免疫组在免疫后4、8和20周显著增加。
- 该细胞群数量在免疫后20周时下降。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A vaccine against tuberculosis (TB), a disease resulting from infection with Mycobacterium tuberculosis (M.tb), is urgently needed to prevent more than a million deaths per year. Bacillus Calmette-Guérin (BCG) is the only available vaccine against TB but its efficacy varies throughout the world. Subunit vaccine candidates, based on recombinant viral vectors expressing mycobacterial antigens, are one of the strategies being developed to boost BCG-primed host immune responses and efficacy. A promising vaccination regimen composed of intradermal (i.d.) BCG prime, followed by intranasally (i.n.) administered chimpanzee adenoviral vector (ChAdOx1) and i.n. or i.d. modified vaccinia Ankara virus (MVA), both expressing Ag85A, has been previously reported to significantly improve BCG efficacy in mice. Effector and memory immune responses induced by BCG-ChAdOx1.85A-MVA85A (B-C-M), were evaluated to identify immune correlates of protection in mice. This protective regime induced strong Ag85A-specific cytokine responses in CD4+ and CD8+ T cells, both in the systemic and pulmonary compartments. Lung parenchymal CXCR3+ KLRG1- Ag85A-specific memory CD4+ T cells were significantly increased in B-C-M compared to BCG immunised mice at 4, 8 and 20 weeks post vaccination, but the number of these cells decreased at the latter time point. This cell population was associated with the protective efficacy of this regime and may have an important protective role against M.tb infection.
引用
- Pinpathomrat N, Bull N, Pasricha J, et al. Using an effective TB vaccination regimen to identify immune responses associated with protection in the murine model. Vaccine. 2021. PMID: 33549390. doi:10.1016/j.vaccine.2021.01.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。